Medizinische Sicherheit und globale Gesundheit
Offener Zugang

Abstrakt

Global Pharmacovigilance 2018-Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan- Farooq Sher- University of Nottingham

Farooq Sher

Adverse drug reaction (ADR) is well-defined by World Health Organisation (WHO) as ‘Any reaction to the drug that is unintended, noxious, and occurs at doses used for diagnosis, prophylaxis and therapy without failure to accomplish to the planned response. ADR is a major problem that occurs worldwide. Health professionals played a role in reporting of ADR around the world which has led to the detection of serious and rare ADR that were previously undetectable and many drugs like “rofecoxib” were withdrawn in the past, so enhancing the safety of. It has been notified in the past that ADR reporting has been provided early to the warning signs and therefore increases the patient safety. Pharmacovigilance and there report of adverse drug reaction were started after the thalidomide disaster in the mid-20th century (Canto, 2010).Adverse drug reactions are the 4 6th leading cause of the death. Patients who are qualified adverse drug reaction was are hospitalised 8 to12 days lengthier than the those who did not qualified adverse drug events and their hospitalised cost is between $16,000–24,000 . Countries with the lack of ADR reportage system are not able to protect their population from the harmful effect of medicines so the effective system of ADR reporting is very important to improve patient care safety and in turn improving overall fitness.